These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24473850)

  • 1. [Statins and ASS for primary prevention of cardiovascular and cerebrovascular disease].
    Goltz L; Bodechtel U; Siepmann T
    Dtsch Med Wochenschr; 2014 Feb; 139(6):283-6. PubMed ID: 24473850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of acetylsalicylic acid by physicians and in the community.
    Mahon J; Steel K; Feagan BG; Laupacis A; Pederson LL
    CMAJ; 1991 Nov; 145(9):1107-16. PubMed ID: 1751930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
    Naderi SH; Bestwick JP; Wald DS
    Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.
    De Socio GV; Ricci E; Parruti G; Calza L; Maggi P; Celesia BM; Orofino G; Madeddu G; Martinelli C; Menzaghi B; Taramasso L; Penco G; Carenzi L; Franzetti M; Bonfanti P
    Infection; 2016 Oct; 44(5):589-97. PubMed ID: 27048184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation of statin therapy and primary prevention of nonfatal cardiovascular events.
    Shalev V; Goldshtein I; Porath A; Weitzman D; Shemer J; Chodick G
    Am J Cardiol; 2012 Dec; 110(12):1779-86. PubMed ID: 23021514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
    Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
    G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acetylsalicylic acid in the treatment of cardiovascular and cerebrovascular diseases].
    Landmark K
    Tidsskr Nor Laegeforen; 1997 Dec; 117(30):4432-6. PubMed ID: 9456592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions.
    Hennekens CH; Dalen JE
    Am J Med; 2013 May; 126(5):373-8. PubMed ID: 23499330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statins in primary prophylaxis of cardiovascular diseases].
    Kobalava ZhD; Villeval'de SV
    Ter Arkh; 2011; 83(9):70-5. PubMed ID: 22145392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
    Minder CM; Blumenthal RS; Blaha MJ
    Curr Opin Cardiol; 2013 Sep; 28(5):554-60. PubMed ID: 23928920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of cardiovascular drugs in the treatment of cerebrovascular disease.
    Bösel J; Amiri H
    Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use.
    Maggi P; De Socio GV; Cicalini S; D'Abbraccio M; Dettorre G; Di Biagio A; Martinelli C; Nunnari G; Rusconi S; Sighinolfi L; Spagnuolo V; Squillace N
    AIDS Res Ther; 2019 May; 16(1):11. PubMed ID: 31126301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
    Moyad MA; Merrick GS
    Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study.
    Lopez-Carmona D; Bernal-Lopez M; Mancera-Romero J; Jansen-Chaparro S; Portales-Fernandez I; Baca-Osorio AJ; Perez-Gonzalez R; Tinahones FJ; Gomez-Huelgas R
    Eur J Prev Cardiol; 2012 Oct; 19(5):1074-81. PubMed ID: 21810843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
    Chen YH; Feng B; Chen ZW
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acetylsalicylic acid in primary prevention of cardiovascular events; literature study].
    Bredie SJ; Wollersheim HC; Verheugt FW; Thien T
    Ned Tijdschr Geneeskd; 2002 Jan; 146(2):68-72. PubMed ID: 11820060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.